US Stock Market Live | Dow Jones | Nasdaq Today | Global markets surged after Trump ruled out firing Fed Chair Powell and ...

Truist lowered the firm’s price target on Regeneron (REGN) to $975 from $1,004 and keeps a Buy rating on the shares. The firm notes Regeneron ...

Analysts have given Gilead Sciences a total of 15 ratings, with the consensus rating being Outperform. The average one-year ...

Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicineHOLLY SPRINGS, N.C., April 23, 2025 -- ...

The comanagers look for stocks that not only pay dividends, but ones that also make their dividend policies a key feature of their capital allocation strategy. They target firms with at least a ...

James Fishback, an investment manager who briefly worked with Vivek Ramaswamy in the earliest days of the Department of Government Efficiency (DOGE), says the idea of “DOGE dividend” payments ...

It earns an Above Average Process rating. Santoro's process focuses on stocks with steady and increasing dividends, while also looking beyond the dividend. The team examines cash flows ...

The company said this morning that the COAST trial of sozinibercept (OPT-302) as a combination therapy with blockbuster wet AMD therapy Regeneron/Bayer's Eylea (aflibercept) wasn't able to show ...